Diary - News
All news BIOASTER in collaboration with Janssen and the CRCL
BIOASTER, and Cancer Center of Lyon (CRCL, France) represented by its managing partners INSERM1, CNRS2, UCBL3 and CLB4, have signed a contract with Janssen-Cilag SAS, one of the Janssen Pharmaceutical Companies of Johnson & Johnson to advance the global fight against chronic hepatitis B virus (HBV). The collaboration is jointly coordinated by Janssen France and Johnson & Johnson Innovation.